Related Experiment Video
Updated: Mar 21, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Sirolimus Therapy in Generalized Lymphatic Anomaly With Tuberculosis: A Case Report
Kamal K Singhal1, Piali Mandal1, Varinder Singh1
1Department of Pediatrics, Lady Hardinge Medical College & Kalawati Saran Children's Hospital, New Delhi, India.
This case study details a rare instance of Generalized Lymphatic Anomaly (GLA) co-occurring with tuberculosis in a pediatric patient. Combined sirolimus and anti-tubercular therapy led to sustained clinical improvement.
Area of Science:
- Pediatric Medicine
- Vascular Anomalies
- Infectious Diseases
Background:
- Generalized Lymphatic Anomaly (GLA) is a rare condition affecting lymphatic vessels.
- Tuberculosis can present with diverse clinical manifestations, including pleural effusions.
- Co-occurrence of GLA and tuberculosis is exceptionally rare.
Purpose of the Study:
- To report a unique case of a critically ill child with coexisting Generalized Lymphatic Anomaly and tuberculosis.
- To highlight the diagnostic and therapeutic challenges in managing dual pathology.
- To emphasize the importance of considering concurrent infections in complex pediatric cases.
Main Methods:
- Clinical case presentation of a 14-year-old female.
- Diagnostic workup including radiological evaluation and pleural fluid cultures.
- Therapeutic interventions involving medications for GLA and tuberculosis.
Main Results:
- Radiological diagnosis of Generalized Lymphatic Anomaly (GLA) was established.
- Pleural fluid analysis revealed Mycobacterium tuberculosis.
- Combined treatment with sirolimus and anti-tubercular therapy (ATT) resulted in sustained clinical improvement.
Conclusions:
- This case underscores the rare coexistence of Generalized Lymphatic Anomaly and tuberculosis.
- Persistent pleural effusions in children warrant consideration for dual pathology.
- Multifaceted treatment approaches are crucial for managing complex pediatric conditions.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...